The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma

Medical Science Monitor

Volumn 11, Issue 2, 2005, Pages

  Elahi, Maqsood M ^a,c   McMillan, Donald C ^a   McArdle, Colin S ^a   Angereon, Wilson J ^a   Soukop, Michael ^a   Johnstone, Jennie ^b   Sattar, Naveed ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NHS Greater Glasgow and Clyde Clinical Biochemistry Service   (United Kingdom)

^c LEICESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Albumin; C reactive protein; Lymphoma; Survival

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN;

ADULT; ADVANCED CANCER; ALBUMIN BLOOD LEVEL; CANCER MORTALITY; CANCER SURVIVAL; CONFIDENCE INTERVAL; FEMALE; HODGKIN DISEASE; HUMAN; INFLAMMATION; LYMPHOMA; MALE; NONHODGKIN LYMPHOMA; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; REVIEW; SURVIVAL TIME; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UNITED KINGDOM;

C-REACTIVE PROTEIN; FEMALE; HUMANS; INFLAMMATION; LYMPHOMA; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 13844292640     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. DuClos TW: Function of C-reactive protein. Ann Med, 2000; 32: 274-78
2. Mahmoud FA, Rivera NI: The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep, 2002; 4: 250-55
3. McMillan DC, Wotherspoon HA, Fearon KCH et al: A prospective study of tumour recurrence and the acute phase response after apparently curative colorectal cancer. Am J Surgery, 1995; 170: 319-22
4. Falconer JS, Fearon KC, Ross JA et al: Acute-phase protein response and survival duration of patients with pancreatic cancer. Cancer, 1995; 75: 2077-82
5. Nielsen HJ, Chritensen IB, Sørensen S et al: Preoperative plasma Plasminogen Activator inhibitor Type-1 and serum C-reactive protein levels in patients with colorectal cancer. Ann Surg Oncol, 2000; 7: 617-23
6. Scott HR, McMillan DC, Forrest LM et al: The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer, 2002; 87: 264-67
7. Legouffe E, Rodriguez C, Picot MC et al: C-reactive protein serum level is a valuable and simple prognostic marker in non Hodgkin's lymphoma. Leuk Lymphoma, 1998; 31: 351-75
8. Matkovic S, Jelic S, Manojlovic N, Milanovic N: Non-Hodgkin's lymphomas with primary localisation in large bowel and rectum. Med Sci Monit, 2000; 6(3): 512-18
9. Woszczyk D, Gola J, Jurzak M et al: Expression of TGF beta-1 genes and their receptor types I, II, and III in low-and high-grade malignancy non-Hodgkin's lymphomas. Med Sci Monit, 2004; 10(1): CR33-CR37
10. McMillan DC, Elahi M, Sattar N et al: Measurement of the systemic inflammatory response predicts cancer specific and non-cancer survival in patients with cancer. Nutrition and Cancer, 2001; 41: 64-69
11. Christakis NA, Lamont EB: Extent and determinants of error in doctors' prognoses in terminally ill patients: prospective cohort study. BMJ, 2000; 320: 469-72
12. Fearon KC, McMillan DC, Preston T et al: Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg. 1991; 213: 26-31
13. Moldawer LL, Copeland EM III: Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer, 1997; 79: 1828-39
14. Folkman J: Angiogenesis in cancer, vascular, and rheumatoid and other disease. Nat Med, 1995; 1: 27-31
15. Salven P, Orpana A, Teerenhovi L, Joensuu H: Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin's lymphoma: a single-institution study of 200 patients. Blood, 2000; 96: 3712-18
16. Maeno N, Takei S, Imanaka H et al: Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis. J Rheumatol, 1999; 26: 2244-48
17. Soeki T, Tamura Y, Shinohara H et al: Serial changes in serum VEGF and HGF in patients with acute myocardial infarction. Cardiology, 2000; 93: 168-74
18. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation, 2002; 105: 1135-43
19. Retterstol L, Eikvar L, Bohn M et al: C-reactive protein predicts death in patients with previous premature myocardial infarction-a 10 year follow-up study. Atherosclerosis, 2002; 160: 433-40
20. Ridker PM: Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet, 2001; 358(9286): 946-48